These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21715106)

  • 1. Could a continuous measure of individual transmissible risk be useful in clinical assessment of substance use disorder? Findings from the National Epidemiological Survey on Alcohol and Related Conditions.
    Ridenour TA; Kirisci L; Tarter RE; Vanyukov MM
    Drug Alcohol Depend; 2011 Dec; 119(1-2):10-7. PubMed ID: 21715106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking.
    Moss HB; Chen CM; Yi HY
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1073-83. PubMed ID: 20374206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Externalizing behavior and emotion dysregulation are indicators of transmissible risk for substance use disorder.
    Kirisci L; Tarter R; Ridenour T; Reynolds M; Horner M; Vanyukov M
    Addict Behav; 2015 Mar; 42():57-62. PubMed ID: 25462655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation among HPA and HPG neuroendocrine systems, transmissible risk and neighborhood quality on development of substance use disorder: results of a 10-year prospective study.
    Tarter RE; Kirisci L; Kirillova G; Reynolds M; Gavaler J; Ridenour T; Horner M; Clark D; Vanyukov M
    Drug Alcohol Depend; 2013 Jan; 127(1-3):226-31. PubMed ID: 22867990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the Transmissible Liability Index (TLI) and Adolescent Cannabis Use Predict Paranoid and Schizotypal Symptoms at Young Adulthood?
    Sharma P; Riehm KE; Young AS; Reynolds MD; Tarter RE; Horner MS; Hammond CJ
    Subst Use Misuse; 2021; 56(13):2026-2034. PubMed ID: 34402373
    [No Abstract]   [Full Text] [Related]  

  • 6. Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders.
    Tsai J; Gu X
    Addict Sci Clin Pract; 2019 Mar; 14(1):9. PubMed ID: 30836991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.
    Hasin D; Fenton MC; Skodol A; Krueger R; Keyes K; Geier T; Greenstein E; Blanco C; Grant B
    Arch Gen Psychiatry; 2011 Nov; 68(11):1158-67. PubMed ID: 22065531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.
    Latvala A; Tuulio-Henriksson A; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Korhonen T; Koskinen S; Lönnqvist J; Kaprio J; Suvisaari J
    BMC Psychiatry; 2009 Nov; 9():73. PubMed ID: 19925643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?
    Cornelius JR; Kirisci L; Reynolds M; Vanyukov M; Tarter R
    Am J Drug Alcohol Abuse; 2015 May; 41(3):264-8. PubMed ID: 25699562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring liability for substance use disorder among college students: implications for screening and early intervention.
    Arria AM; Vincent KB; Caldeira KM
    Am J Drug Alcohol Abuse; 2009; 35(4):233-41. PubMed ID: 20180676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the association between sexual maturation, transmissible risk, and peer relationships during childhood and adolescence on development of substance use disorder in young adulthood.
    Horner MS; Tarter R; Kirisci L; Clark DB
    Am J Addict; 2013; 22(5):474-80. PubMed ID: 23952893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Modeling of the Association Between Transmissible Risk, Affect During Drug Use and Development of Substance Use Disorder.
    Tarter RE; Kirisci L; Reynolds M; Horner M; Zhai Z; Gathuru I; Vanyukov M
    J Addict Med; 2015; 9(6):464-9. PubMed ID: 26441401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study.
    McCabe SE; West BT
    J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomes.
    Hicks BM; Iacono WG; McGue M
    Drug Alcohol Depend; 2012 Jun; 123 Suppl 1():S18-23. PubMed ID: 22245078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample.
    Magidson JF; Liu SM; Lejuez CW; Blanco C
    J Psychiatr Res; 2012 May; 46(5):659-66. PubMed ID: 22444600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Alegría AA; Hasin DS; Nunes EV; Liu SM; Davies C; Grant BF; Blanco C
    J Clin Psychiatry; 2010 Sep; 71(9):1187-95; quiz 1252-3. PubMed ID: 20923623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does stress mediate the development of substance use disorders among youth transitioning to young adulthood?
    Cornelius J; Kirisci L; Reynolds M; Tarter R
    Am J Drug Alcohol Abuse; 2014 May; 40(3):225-9. PubMed ID: 24735415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of alcohol combined with other substance use disorders in an American Indian community sample.
    Gilder DA; Stouffer GM; Lau P; Ehlers CL
    Drug Alcohol Depend; 2016 Apr; 161():222-9. PubMed ID: 26896167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.
    McCabe SE; West BT; Strobbe S; Boyd CJ
    J Subst Abuse Treat; 2018 Oct; 93():38-48. PubMed ID: 30126540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use disorders increase the odds of subsequent mood disorders.
    Kenneson A; Funderburk JS; Maisto SA
    Drug Alcohol Depend; 2013 Dec; 133(2):338-43. PubMed ID: 23906994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.